State Street’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

State Street’s Portfolio CYTH Stock Details CYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-39,530	Closed	-$23.3K	–	4315
2024 Q4	$23.3K	Hold	39,530	–	–	﹤0.01%	4222
2024 Q3	$31.2K	Hold	39,530	–	–	﹤0.01%	4167
2024 Q2	$50.2K	Hold	39,530	–	–	﹤0.01%	4139
2024 Q1	$54.9K	Buy	39,530 +5	+0%	+$8	﹤0.01%	4142
2023 Q4	$62.8K	Buy	39,525 +7,325	+23%	+$9.34K	﹤0.01%	4154
2023 Q3	$45.7K	Buy	32,200 +3,900	+14%	+$6K	﹤0.01%	4309
2023 Q2	$45K	Hold	28,300	–	–	﹤0.01%	4444
2023 Q1	$23.8K	Hold	28,300	–	–	﹤0.01%	4657
2022 Q4	$40.2K	Hold	28,300	–	–	﹤0.01%	4608
2022 Q3	$55K	Hold	28,300	–	–	﹤0.01%	4637
2022 Q2	$57K	Hold	28,300	–	–	﹤0.01%	4697
2022 Q1	$90K	Hold	28,300	–	–	﹤0.01%	4673
2021 Q4	$106K	Sell	28,300 -1,300	-4%	-$7.36K	﹤0.01%	4566
2021 Q3	$200K	Sell	29,600 -15,100	-34%	-$118K	﹤0.01%	4360
2021 Q2	$457K	Buy	+44,700	New	+$374K	﹤0.01%	3890

State Street's CYTH Position: Q1 2025 in Review

State Street sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q1 2025, closing a stake of 39,530 shares — an estimated $23.3K sold.

State Street first reported a position in CYTH in Q2 2021 and held it in 15 quarters. The position peaked at $457K in Q2 2021. 0 funds tracked by Wall St. Rank hold CYTH as of Q1 2025.

State Street reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
State Street sold 39,530 Cyclo Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $23.3K.
State Street first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
State Street's Cyclo Therapeutics, Inc. Common Stock position peaked at $457K in Q2 2021.
0 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.